20 Nov Next Generation Therapeutics for the Treatment of Myelofibrosis
Posted at 10:13h in Blogs 0 Comments
Multiple non-JAK inhibitor-based therapies are being explored in pre-clinical and clinical settings for the treatment of myelofibrosis, targeting outside of the JAK-STAT pathway. (Ref: Tremblay D et al. Cells. 2021)
Sorry, the comment form is closed at this time.